Bolukbasi Yasemin, Onal Cem, Ozsaran Zeynep, Senyurek Sukran, Akdemir Eyub Yasar, Selek Ugur, Yıldız Ferah
Department of Radiation Oncology, Faculty of Medicine, Koç University, Istanbul, Turkey.
Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
J Contemp Brachytherapy. 2021 Apr;13(2):152-157. doi: 10.5114/jcb.2021.105282. Epub 2021 Apr 14.
The American Brachytherapy Association is attempting to develop standards for delivering brachytherapy, although differences in practice have been reported in the literature. This study evaluated vaginal cuff brachytherapy (VBT) practice and quality of life-related recommendations among Turkish radiation oncologists.
A nationwide web-based 17-item survey was distributed to the members of the Turkish Society for Radiation Oncology. These members received e-mail notifications, and a link was posted on the Turkish Society for Radiation Oncology internet site to solicit voluntary responses The survey addressed the simulation processes, target volume, prescribed dose, delivery schedules, and recommendations related to vaginal side effects.
Fifty-seven radiation oncologists responded to the survey. The most used dose fraction schemes for adjuvant VBT were 7 Gy × 3 fractions (30%), 5.5 Gy × 5 fractions (26%), and 6 Gy × 5 fractions (28%). The preferred VBT scheme was 5 Gy × 3 fractions (50%) when the external beam radiotherapy (EBRT) dose was 45 Gy external radiotherapy, while the preferred schemes were 6 Gy × 3 fractions (30%) or 5 Gy × 3 fractions (32%) when the external radiotherapy dose was increased to 50.4 Gy. One-half of the respondents delivered VBT twice a week, and the dose was prescribed to 0.5 cm from vaginal mucosa by 86% of the respondents. There was no common definition for the dose prescription length, which was defined as 3 cm from the vaginal cuff in 33% of responses and as 4 cm in 35% of responses. For serous and clear cell histological types, 38% of the respondents targeted "full cylinder length". To prevent vaginal side effects, 78% of the respondents recommended using a vaginal dilator and/or sexual intercourse after VBT.
This survey revealed variations in the clinical practice of VBT among Turkish radiation oncologists, which suggests that standardization is necessary.
美国近距离放射治疗协会正在尝试制定近距离放射治疗的标准,尽管文献中已报道了实践中的差异。本研究评估了土耳其放射肿瘤学家在阴道残端近距离放射治疗(VBT)方面的实践情况以及与生活质量相关的建议。
向土耳其放射肿瘤学会的成员发放了一份基于网络的包含17个项目的全国性调查问卷。这些成员收到了电子邮件通知,并且在土耳其放射肿瘤学会的网站上发布了一个链接以征集自愿回复。该调查涉及模拟过程、靶区体积、处方剂量、治疗计划以及与阴道副作用相关的建议。
57名放射肿瘤学家回复了该调查。辅助性VBT最常用的剂量分割方案是7 Gy×3次分割(30%)、5.5 Gy×5次分割(26%)以及6 Gy×5次分割(28%)。当外照射放疗(EBRT)剂量为45 Gy时,首选的VBT方案是5 Gy×3次分割(50%),而当外照射放疗剂量增加到50.4 Gy时,首选方案是6 Gy×3次分割(30%)或5 Gy×3次分割(32%)。一半的受访者每周进行两次VBT,86%的受访者将剂量处方到距阴道黏膜0.5 cm处。剂量处方长度没有统一的定义,33%的回复将其定义为距阴道残端3 cm,35%的回复将其定义为4 cm。对于浆液性和透明细胞组织学类型,38%的受访者将“整个阴道筒长度”作为靶区。为预防阴道副作用,78%的受访者建议在VBT后使用阴道扩张器和/或进行性交。
本次调查揭示了土耳其放射肿瘤学家在VBT临床实践中的差异,这表明有必要进行标准化。